ES2153394T3 - Medicamento que contiene la subunidad p40 de interleuquina-12. - Google Patents
Medicamento que contiene la subunidad p40 de interleuquina-12.Info
- Publication number
- ES2153394T3 ES2153394T3 ES94105595T ES94105595T ES2153394T3 ES 2153394 T3 ES2153394 T3 ES 2153394T3 ES 94105595 T ES94105595 T ES 94105595T ES 94105595 T ES94105595 T ES 94105595T ES 2153394 T3 ES2153394 T3 ES 2153394T3
- Authority
- ES
- Spain
- Prior art keywords
- medicinal product
- subunity
- product containing
- interleuquina
- interleuquin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN MEDICAMENTO QUE CONTIENE LA SUBUNIDAD P40 DEL INTERLEUQUIN 12. ESTE MEDICAMENTO ES ESPECIALMENTE ADECUADO PARA EL TRATAMIENTO DE ENFERMEDADES QUE VAN PAREJAS A LA REGULACION DEFECTUOSA DEL SISTEMA INMUNOLOGICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4315127A DE4315127A1 (de) | 1993-05-07 | 1993-05-07 | Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2153394T3 true ES2153394T3 (es) | 2001-03-01 |
Family
ID=6487416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94105595T Expired - Lifetime ES2153394T3 (es) | 1993-05-07 | 1994-04-12 | Medicamento que contiene la subunidad p40 de interleuquina-12. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5547852A (es) |
EP (1) | EP0625354B1 (es) |
JP (1) | JP3683291B2 (es) |
KR (1) | KR100345254B1 (es) |
AT (1) | ATE198048T1 (es) |
AU (1) | AU676891B2 (es) |
CA (1) | CA2123049C (es) |
DE (2) | DE4315127A1 (es) |
DK (1) | DK0625354T3 (es) |
ES (1) | ES2153394T3 (es) |
GR (1) | GR3035198T3 (es) |
PT (1) | PT625354E (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2125763C (en) * | 1993-07-02 | 2007-08-28 | Maurice Kent Gately | P40 homodimer of interleukin-12 |
US5573764A (en) * | 1994-01-21 | 1996-11-12 | Genetics Institute, Inc. | Use of interleukin-12 to prevent graft versus host disease |
US6706264B1 (en) | 1994-03-14 | 2004-03-16 | Genetics Institute, Llc | Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y |
ZA95960B (en) † | 1994-03-14 | 1995-10-10 | Genetics Inst | Use of interleukin-12 antagonists in the treatment of autoimmune diseases |
US5665347A (en) * | 1995-02-02 | 1997-09-09 | Genetics Institute | IL-12 inhibition of B1 cell activity |
WO1996024369A1 (en) * | 1995-02-06 | 1996-08-15 | Genetics Institute, Inc. | Formulations for il-12 |
US5853697A (en) * | 1995-10-25 | 1998-12-29 | The United States Of America, As Represented By The Department Of Health & Human Services | Methods of treating established colitis using antibodies against IL-12 |
WO1997020062A1 (en) * | 1995-12-01 | 1997-06-05 | University Of Massachusetts | Il-12 p40 subunit fusion polypeptides and uses thereof |
US6187564B1 (en) | 1997-07-10 | 2001-02-13 | Beth Israel Deaconess Medical Center | DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics |
US6242570B1 (en) | 1997-07-10 | 2001-06-05 | Beth Israel Deaconess Medical Center | Production and use of recombinant protein multimers with increased biological activity |
US6165476A (en) * | 1997-07-10 | 2000-12-26 | Beth Israel Deaconess Medical Center | Fusion proteins with an immunoglobulin hinge region linker |
ATE389019T1 (de) * | 1999-09-09 | 2008-03-15 | Schering Corp | Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen |
EP1905832A3 (en) * | 1999-09-09 | 2009-09-09 | Schering Corporation | Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
US7090847B1 (en) | 1999-09-09 | 2006-08-15 | Schering Corporation | Mammalian cytokines; related reagents and methods |
US7115712B1 (en) * | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
US6902734B2 (en) * | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
CA2536819A1 (en) * | 2003-08-26 | 2005-03-03 | The Council Of The Queensland Institute Of Medical Research | Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium spp |
EA016022B1 (ru) | 2004-12-21 | 2012-01-30 | Сентокор, Инк. | Выделенное антитело млекопитающего против il-12 и способ изменения его активности |
US9018006B2 (en) | 2010-07-23 | 2015-04-28 | The University Of Toledo | Stable Tregs and related materials and methods |
NO2709651T3 (es) | 2011-05-19 | 2018-03-03 | ||
AU2017241776A1 (en) | 2016-03-29 | 2018-10-11 | Janssen Biotech, Inc. | Treating psoriasis with increased interval dosing of anti-IL12 and/or -23 antibody |
TW201922780A (zh) * | 2017-09-25 | 2019-06-16 | 美商健生生物科技公司 | 以抗il12/il23抗體治療狼瘡之安全且有效之方法 |
US11578124B2 (en) | 2018-05-18 | 2023-02-14 | Janssen Biotech, Inc. | Safe and effective method of treating lupus with anti-IL12/IL23 antibody |
FI3883606T3 (fi) | 2018-09-24 | 2023-09-07 | Janssen Biotech Inc | Turvallinen ja tehokas menetelmä haavaisen paksusuolitulehduksen hoitamiseksi anti-il12/il23-vasta-aineella |
AU2020279987A1 (en) | 2019-05-23 | 2021-11-18 | Janssen Biotech, Inc. | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2893653B2 (ja) * | 1988-11-10 | 1999-05-24 | ジェネティックス・インスティテュート・インコーポレイテッド | ナチュラルキラー細胞刺激因子 |
US5296353A (en) * | 1992-04-06 | 1994-03-22 | The United States Of America As Represented By The Department Of Health And Human Services | Evaluation and treatment of patients with progessive immunosuppression |
-
1993
- 1993-05-07 DE DE4315127A patent/DE4315127A1/de not_active Withdrawn
-
1994
- 1994-04-12 DK DK94105595T patent/DK0625354T3/da active
- 1994-04-12 ES ES94105595T patent/ES2153394T3/es not_active Expired - Lifetime
- 1994-04-12 AT AT94105595T patent/ATE198048T1/de active
- 1994-04-12 DE DE59409604T patent/DE59409604D1/de not_active Expired - Lifetime
- 1994-04-12 PT PT94105595T patent/PT625354E/pt unknown
- 1994-04-12 EP EP94105595A patent/EP0625354B1/de not_active Expired - Lifetime
- 1994-04-29 US US08/235,321 patent/US5547852A/en not_active Expired - Lifetime
- 1994-05-05 AU AU61901/94A patent/AU676891B2/en not_active Ceased
- 1994-05-06 CA CA2123049A patent/CA2123049C/en not_active Expired - Fee Related
- 1994-05-06 KR KR1019940009898A patent/KR100345254B1/ko not_active IP Right Cessation
- 1994-05-09 JP JP11952194A patent/JP3683291B2/ja not_active Expired - Fee Related
-
2001
- 2001-01-10 GR GR20010400016T patent/GR3035198T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2123049A1 (en) | 1994-11-08 |
US5547852A (en) | 1996-08-20 |
CA2123049C (en) | 2010-07-06 |
GR3035198T3 (en) | 2001-04-30 |
KR100345254B1 (ko) | 2003-08-02 |
DE4315127A1 (de) | 1994-11-10 |
AU6190194A (en) | 1994-11-10 |
AU676891B2 (en) | 1997-03-27 |
ATE198048T1 (de) | 2000-12-15 |
PT625354E (pt) | 2001-03-30 |
JPH06329549A (ja) | 1994-11-29 |
DK0625354T3 (da) | 2001-01-22 |
DE59409604D1 (de) | 2001-01-18 |
EP0625354A1 (de) | 1994-11-23 |
JP3683291B2 (ja) | 2005-08-17 |
EP0625354B1 (de) | 2000-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2153394T3 (es) | Medicamento que contiene la subunidad p40 de interleuquina-12. | |
ES2102367T3 (es) | Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion. | |
MX9301929A (es) | Derivados de pirimidina y procedimientos para su preparacion. | |
ES2176480T3 (es) | Derivados acilados de la melatonina y de analogos como medicamentos. | |
MX16658A (es) | Procedimiento para la preparacion de derivados delacido difosfonico producto obtenido y composicion farmaceutica para el tratamiento de desordenes en el metabolismo del calcio que lo incluye. | |
ES2160124T3 (es) | Utilizacion de bcl-2 para la fabricacion de medicamentos para el tratamiento terapeutico y la prevencion de enfermedades. | |
DE3382641D1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
BR9407720A (pt) | Composto composiçao farmacêutica e processo para a prevençao ou tratamento de pertubaçoes imunorreguladoras ou doenças que compreendem a administraçao do composto | |
NL300224I2 (nl) | 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl- of indanylalkylaminoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen. | |
PT787489E (pt) | Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico | |
ES2093440T3 (es) | Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos. | |
ES2078507T3 (es) | Medicinas y derivados de sulfonanilida. | |
MX9300045A (es) | Derivados novedosos de 4.13-dioxabiciclo 8.2.1.tridecenona, procedimientos novedosos y productos intermedios novedosos para su preparacion, y medicamentos novedosos que contienen estos compuestos. | |
FR2521995B1 (es) | ||
ES2184880T3 (es) | Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos. | |
FR2651435B1 (es) | ||
ES2086359T3 (es) | R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto. | |
CO4700299A1 (es) | Derivados de piperazina, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion | |
ES2122221T3 (es) | Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2080452T3 (es) | Uso de bifosfonatos para la fabricacion de un medicamento para el bloqueo de la transformacion neoplasica de celulas inducida por oncogenes ras. | |
ES2135023T3 (es) | Utilizacion de un decapeptido con actividad de tipo benzodiazepina para la preparacion de medicamentos y complementos alimentarios. | |
AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
ES2071939T3 (es) | Nuevos productos esteroides que comprenden un radical espiro en posicion 17, su procedimiento de preparacion y los productos intermedios de este procedimiento, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
ES2156584T3 (es) | Androgenos para estimular el sistema nervioso central. | |
ES2158309T3 (es) | Fenilamidinas sustituidas, medicamentos que contienen a estos compuestos y procedimiento para su preparacion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 625354 Country of ref document: ES |